|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Crescendo Bioscience®
| | | Phone: | (650) 351-1354 | Fax: | (650) 871-7155 | Year Established: | 2002 | Ticker: | MYGN | Exchange: | NASDAQ | Main Contact: | Lucy Lu, Senior VP, Corporate and Business Development | | Other Contacts: | Timothy G. Henn, VP, Finance & Controller Brian Bertha, CBO Ted Snelgrove, CCO Alex Bangs, CIO David Chernoff, MD, Senior VP, Medical Affairs William Hagstrom, President & CEO Oscar Segurado, MD, Ph.D., CMO
| | Company Description | Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, is a molecular diagnostics company focused in rheumatology that develops quantitative, objective, blood tests to provide rheumatologists with deeper clinical insights to help enable more effective management of patients with autoimmune and inflammatory diseases.
Myriad Genetics acquired Crescendo Bioscience in 2014 for $270 million in cash. | |
|
|
|
|
|